Fundraising Fox

Delphi Diagnostics

Austin, US · Founded 2016 · Texas corporation · 2 known investors

delphi-diagnostics.com ↗

Delphi Diagnostics develops genomic diagnostic tests to personalize breast cancer treatment for healthcare providers. The company's Endocrine Activity Index measures endocrine transcriptional activity in early-stage hormone receptor-positive breast cancer to help optimize chemotherapy decisions and improve patient outcomes.

BiotechDigital HealthHealthtechMedical Devicesin /delphi-diagnostics-inc

Founders & leadership

WC
William CreechExecutive Officer

Investors · 2

aVentureSan Francisco
DigitalDx VenturesMenlo Park

Reported raises · per SEC filings

Form D private placements
▶$50MofferedJun 2021 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Winz CasagrandeExecutive Officer, Director
  • Fidel ReijerseDirector
  • Paul SmithDirector
Offering amount
$50M
Incorporated
Corporation, Texas, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$470KraisedJan 2017 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William CreechExecutive Officer
Offering amount
$1M
Amount sold
$470K
First sale
Jan 2017
Incorporated
Corporation, Texas, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news